Mersana Therapeutics Inc (MRSN)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 5.57M | 14.69M | 7.8M | 10.65M | 7.7M | 10.7M | 9.25M | 2.29M |
Operating Income | -59.64M | -45.83M | -57.8M | -56.5M | -43.94M | -21.43M | -21M | -25.46M |
Pre Tax Income | -59.81M | -44.92M | -56.16M | -54.31M | -41.66M | -19.54M | -19.31M | -24.27M |
Net Income | -59.81M | -44.92M | -56.16M | -54.31M | -41.66M | -19.54M | -19.31M | -24.27M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -59.64M | -45.83M | -57.8M | -56.5M | -43.94M | -21.43M | -21M | -25.46M |
EBITDA | -59.43M | -45.54M | -57.48M | -56.18M | -43.51M | -20.98M | -20.58M | -25.05M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 25.17M | 17.55M | 10.59M | 42.12M | 828k | 43k | 26.58M | 36.86M |
Operating Income | -13.82M | -39.62M | -65.66M | -30.2M | -88.11M | -168.86M | -203.77M | -179.67M |
Pre Tax Income | -13.7M | -38.71M | -64.26M | -28.21M | -88.05M | -170.06M | -204.21M | -171.67M |
Net Income | -13.7M | -38.71M | -64.26M | -28.21M | -88.05M | -170.06M | -204.21M | -171.67M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -2.352 | -1.7 | -2.766 | -0.621 | -1.279 | -2.307 | -1.961 | -1.424 |
EBIT | -13.82M | -39.62M | -65.66M | -30.2M | -88.11M | -168.86M | -203.77M | -179.67M |
EBITDA | -13.17M | -38.69M | -64.4M | -28.96M | -87.1M | -168M | -202.84M | -178.15M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.